Bromodeoxyuridine 2026-10-20
A brominated thymidine analogue incorporated during DNA synthesis. Substitution changes buoyant density, allowing copied strands to be distinguished from unsubstituted strands.
Base composition changes both the initial buoyant density and the size of the BUdR-induced density increment. The fraction-number axis runs toward lower density. The unlabelled viral peak lies at a lower fraction number than the corresponding host peak, consistent with viral DNA having a higher GC content. BUdR replaces thymidine in newly synthesized strands, so relatively AT-rich DNA incorporates more brominated nucleoside per unit length and undergoes a larger density increase.
Consequently the more AT-rich host DNA can overtake the viral DNA in the fully substituted class: the host fully heavy peak is slightly farther toward the dense end, although host unlabelled DNA was less dense. The hybrid peaks are intermediate. A useful qualitative model is , and , where is GC fraction, increases with , and decreases as the thymidine fraction decreases. Unequal substitution efficiencies could contribute, but different replication mechanisms are unnecessary. These are equilibrium density positions, not molecular-length measurements.